The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells ; volume:7 ; number:1 ; day:18 ; month:4 ; year:2019 ; pages:1-13 ; date:12.2019
Journal for ImmunoTherapy of Cancer ; 7, Heft 1 (18.4.2019), 1-13, 12.2019
- Urheber
-
Bol, Kalijn F.
Schreibelt, Gerty
Rabold, Katrin
Wculek, Stefanie K.
Schwarze, Julia Katharina
Dzionek, Andrzej
Teijeira, Alvaro
Kandalaft, Lana E.
Romero, Pedro
Coukos, George
Neyns, Bart
Sancho, David
Melero, Ignacio
Vries, I. Jolanda M. de
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-019-0580-6
- URN
-
urn:nbn:de:101:1-2019051319193684762385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bol, Kalijn F.
- Schreibelt, Gerty
- Rabold, Katrin
- Wculek, Stefanie K.
- Schwarze, Julia Katharina
- Dzionek, Andrzej
- Teijeira, Alvaro
- Kandalaft, Lana E.
- Romero, Pedro
- Coukos, George
- Neyns, Bart
- Sancho, David
- Melero, Ignacio
- Vries, I. Jolanda M. de
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Circulating redox status in sheep naturally infected with Trichophyton verrucosum
Elastic Nanovaccine Enhances Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell biology and its role in tumor immunotherapy
Research progress on dendritic cell vaccines in cancer immunotherapy
Negative impact of proteinuria on circulating myeloid dendritic cells
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Naturally
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Circulating redox status in sheep naturally infected with Trichophyton verrucosum
Elastic Nanovaccine Enhances Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell biology and its role in tumor immunotherapy
Research progress on dendritic cell vaccines in cancer immunotherapy
Negative impact of proteinuria on circulating myeloid dendritic cells
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Naturally
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Cytokine-overexpressing dendritic cells for cancer immunotherapy
Circulating redox status in sheep naturally infected with Trichophyton verrucosum
Elastic Nanovaccine Enhances Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell biology and its role in tumor immunotherapy
Research progress on dendritic cell vaccines in cancer immunotherapy
Negative impact of proteinuria on circulating myeloid dendritic cells
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Endogenous/Exogenous Nanovaccines Synergistically Enhance Dendritic Cell‐Mediated Tumor Immunotherapy
Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy